Novartis gets U.S. approval for bigger dose Glatopa MS treatment

loading...


Novartis gets U.S. approval for bigger dose Glatopa MS treatment
ZURICH (Reuters) – Novartis’s Sandoz division said on Tuesday it has won approval in the United States for a larger dosage of its Glatopa treatment for multiple sclerosis patients.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...